UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

PloS one, 2018-05, Vol.13 (5), p.e0196791-e0196791

2018

Volltextzugriff (PDF)

Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure

The Journal of biological chemistry, 2009-09, Vol.284 (36), p.24155-24167

2009

Volltextzugriff (PDF)

Utilization of tyrosine- and histidine-containing dipeptides to enhance productivity and culture viability

Biotechnology and bioengineering, 2012-09, Vol.109 (9), p.2286-2294

2012

Volltextzugriff (PDF)

Progress and challenges in the optimization of toxin peptides for development as pain therapeutics

Current opinion in chemical biology, 2017-06, Vol.38, p.70-79

2017

Volltextzugriff (PDF)

Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS

Journal of pharmacological and toxicological methods, 2009-05, Vol.59 (3), p.171-180

2009

Volltextzugriff (PDF)

Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein

Science (American Association for the Advancement of Science), 2003-02, Vol.299 (5608), p.884-887

2003

Volltextzugriff (PDF)

Probing the S100 protein family through genomic and functional analysis

Genomics (San Diego, Calif.), 2004-07, Vol.84 (1), p.10-22

2004

Volltextzugriff (PDF)

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel

Journal of medicinal chemistry, 2015-03, Vol.58 (5), p.2299-2314

2015

Volltextzugriff (PDF)

Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model

Journal of medicinal chemistry, 2021-03, Vol.64 (6), p.3427-3438

2021

Volltextzugriff (PDF)

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3

Journal of medicinal chemistry, 2015-09, Vol.58 (17), p.6784-6802

2015

Volltextzugriff (PDF)

Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx‑1

ACS chemical biology, 2019-01, Vol.14 (1), p.118-130

2019

Volltextzugriff (PDF)

Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity

Journal of medicinal chemistry, 2008-05, Vol.51 (9), p.2758-2765

2008

Volltextzugriff (PDF)

Engineering Antibody Reactivity for Efficient Derivatization to Generate Na V 1.7 Inhibitory GpTx-1 Peptide-Antibody Conjugates

ACS chemical biology, 2017-09, Vol.12 (9), p.2427-2435

2017

Volltextzugriff (PDF)

Direct Quantitative Analysis of a 20 kDa PEGylated Human Calcitonin Gene Peptide Antagonist in Cynomolgus Monkey Serum Using In-Source CID and UPLC-MS/MS

Journal of the American Society for Mass Spectrometry, 2011-09, Vol.22 (9), p.1660-1667

2011

Volltextzugriff (PDF)

Identification of Potent, Selective, and Metabolically Stable Peptide Antagonists to the Calcitonin Gene-Related Peptide (CGRP) Receptor

Journal of medicinal chemistry, 2008-12, Vol.51 (24), p.7889-7897

2008

Volltextzugriff (PDF)

A Chemical Approach to the Pharmaceutical Optimization of an Anti-HIV Protein

Journal of the American Chemical Society, 2007-10, Vol.129 (43), p.13153-13159

2007

Volltextzugriff (PDF)

Three-Dimensional Solution Structure of α-Conotoxin MII by NMR Spectroscopy: Effects of Solution Environment on Helicity

Biochemistry (Easton), 1998-11, Vol.37 (45), p.15621-15630

1998

Volltextzugriff (PDF)

Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor

The Journal of biological chemistry, 1999-12, Vol.274 (51), p.36559-36564

1999

Volltextzugriff (PDF)

Leu(10) of alpha-conotoxin PnIB confers potency for neuronal nicotinic responses in bovine chromaffin cells

European journal of pharmacology, 2000-03, Vol.390 (3), p.229

2000

Volltextzugriff (PDF)

Isolation and physical characterization of an alpha1-acid-glycoprotein from human serum (author's transl)

Sangre (Zaragoza), 1975, Vol.20 (2), p.113

1975

Volltextzugriff (PDF)

Obtaining monoclonal antibodies against human immunoglobulins

Salud pública de México, 1985-05, Vol.27 (3), p.194-198

1985

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure

Utilization of tyrosine- and histidine-containing dipeptides to enhance productivity and culture viability

Progress and challenges in the optimization of toxin peptides for development as pain therapeutics

Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS

Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein

Probing the S100 protein family through genomic and functional analysis

Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel

Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3

Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx‑1

Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity

Engineering Na V 1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics

Engineering Antibody Reactivity for Efficient Derivatization to Generate Na V 1.7 Inhibitory GpTx-1 Peptide-Antibody Conjugates

Direct Quantitative Analysis of a 20 kDa PEGylated Human Calcitonin Gene Peptide Antagonist in Cynomolgus Monkey Serum Using In-Source CID and UPLC-MS/MS

Identification of Potent, Selective, and Metabolically Stable Peptide Antagonists to the Calcitonin Gene-Related Peptide (CGRP) Receptor

A Chemical Approach to the Pharmaceutical Optimization of an Anti-HIV Protein

Three-Dimensional Solution Structure of α-Conotoxin MII by NMR Spectroscopy: Effects of Solution Environment on Helicity

Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor

Leu(10) of alpha-conotoxin PnIB confers potency for neuronal nicotinic responses in bovine chromaffin cells

Isolation and physical characterization of an alpha1-acid-glycoprotein from human serum (author's transl)

Obtaining monoclonal antibodies against human immunoglobulins

Aktive Filter

Suchergebnisse filtern